Publication Code
IAEA-TECDOC-2057
ID
15707
Publication Type
Description
This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and regulatory aspects of various Ac-225 radiopharmaceuticals. The intended audience also includes radiochemists, radiopharmacists, and medical physicists.
Cover Image
ISBN
978-92-0-121324-2
Publication Original Id
15707
Publication Year
2024
Publication Date
Publication Issue Date
Publication Series Info
2057
Publication Series Number
2057
Price
30.00
Number of Pages
54
Number of Figures
20
Publication Medium
Print (Paper)
Keywords
Production and Quality Control, Actinium-225, Ac-225, Radiopharmaceuticals, Targeted Alpha Therapy, TAT, Formulation, Quality Control, Radiopharmacists, Medical Physicists, Safety Measures, Production Control, Nuclear Medicine, Alpha Emitting Radionuclides, Clinical Use of Ac-225, Actinium-225 Production, Radiochemical Separation, Irradiation, Staff Requirements, Radiopharmaceutical Production, Radiolabelling, Radiation Protection, Shipment of Alpha Emitters, Waste Management, Radiation Safety for Patients
Publication File
Publication File Type
application/pdf
Publication File Size
2232
Skip on import
Off
DOI Url
https://doi.org/10.61092/iaea.95h3-2ji2
feed hash
47462dfcaa2232e2ce8f164a5390ecf6